REFERENCES
- Kitamei H, Kitaichi N, Namba K, et al. Clinical features of intraocular inflammation in Hokkaido, Japan. Acta Ophthalmol. 2009;87:424–428.
- Keino H, Nakashima C, Watanabe T, et al. Frequency and clinical features of intraocular inflammation in Tokyo. Clin Exp Ophthalmol. 2009;37:595–601.
- Hikita S, Sonoda KH, Hijioka K, et al. Incidence of uveitis in the northern Kyushu region of Japan – comparison between the periods of 1996–2001 and 2003–2008. Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc). 2012;116:847–855.
- Miyanaga M, Shimizu K, Kawaguchi T, et al. Clinical survey of uveitis in HTLV-1 endemic region. Ocul Immunol Inflamm. 2009;17:335–341.
- Ohguro N, Sonoda KH, Takeuchi M, et al. The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol. 2012;56:432–435.
- Verdonck K, Gonzalez E, Van Dooren S, et al. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis. 2007;7:266–281.
- Watanabe T. Current status of HTLV-1 infection. Int J Hematol. 2011;94:430–434.
- Kamoi K, Mochizuki M. HTLV-1 uveitis. Front Microbiol. 2012;3:1–4.
- Satake M, Yamaguchi K, Tadokoro K. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol. 2012;84:327–335.
- Uchimaru K, Nakamura Y, Tojo A, et al. Factors predisposing to HTLV-1 infection in residents of the greater Tokyo area. Int J Hematol. 2008;88:565–570.
- Gessain A, Gallo RC, Franchini G. Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. J Virol. 1992;66:2288–2295.
- Ono A, Miura T, Araki S, et al. Subtype analysis of HTLV-1 in patients with HTLV-1 uveitis. Jpn J Cancer Res. 1994;85:767–770.
- Nakao K, Ohba N, Nakagawa M, et al. Clinical course of HTLV-I-associated uveitis. Jpn J Ophthalmol. 1999;43:404–409.
- Kase S, Namba K, Kitaichi N, et al. Clinical features of human T lymphotropic virus type 1-associated uveitis in Hokkaido, Japan. Jpn J Ophthalmol. 2013;57:379–384.
- Shibata K, Shimamoto Y, Nishimura T, et al. Ocular manifestations in adult T-cell leukemia/lymphoma. Ann Hematol. 1997;74:163–168.
- Inaba S, Sato H, Okochi K, et al. Prevention of transmission of human T-lymphotropic virus type 1 (HTLV-1) through transfusion, by donor screening with antibody to the virus. One-year experience. Transfusion. 1989;29:7–11.
- Nerome Y, Kojyo K, Ninomiya Y, et al. Current human T-cell lymphotropic virus type 1 mother-to-child transmission prevention status in Kagoshima. Pediatr Int. 2014;56:640–643.
- Maenz M, Schluter D, Liesenfeld O, et al. Ocular toxoplasmosis past, present and new aspects of an old disease. Prog Retin Eye Res. 2014;39:77–106.
- Holland GN. LX Edward Jackson Memorial Lecture: Ocular toxoplasmosis: a global reassessment. Part I; Epidemiology and course of disease. Am J Ophthalmol. 2003;136:973–988.
- Pleyer U, Schlüter D, Mänz M. Ocular toxoplasmosis: recent aspects of pathophysiology and clinical implications. Ophthalmic Res. 2014;52:116–123.
- Goto H, Mochizuki M, Yamaki K, et al. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol. 2007;51:41–44.
- Sakikawa M, Noda S, Hanaoka M, et al. Anti-toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,166 pregnant women in Japan. Clin Vaccine Immunol. 2012;19:365–367.
- WHO. Global Tuberculosis Report. Geneva: World Health Organization; 2015.
- Urayama A. Etiology of uveitis. Rinsho Ganka. 1960;14:1015–1021.
- Shimouchi A, Ohmori M. City tuberculosis. Kekkaku. 2007;82:345.
- Hoshino H, Uchimura K, Yamauchi Y. Comparison of TB incidence of young and middle age groups between urban/suburban prefectures and other prefectures. Kekkaku. 2009;84:1–8.
- Cunningham ET, Rathinam SR, Albini TA, et al. Tuberculous uveitis. Ocul Immunol Inflamm. 2015;23:2–6.
- Gupta V, Gupta A, Rao NA. Intraocular tuberculosis – an update. Surv Ophthalmol. 2007;52:561–587.
- Morimura Y, Okada AA, Kawahara S, et al. Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan. Ophthalmology. 2002;109:851–857.
- La Distia Nora R, van Velthoven ME, Ten Dam-van Loon NH, et al. Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis. Am J Ophthalmol. 2014;157:754–761.